Detection of extended spectrum β lactamases in Escherichia coli and Klebsiella Pneumoniae with E test
Wen Zhang
Abstract
Wen Zhang
Abstract
OBJECTIVE To detect the extended spectrum β lactamases (ESBLs) and the resistance of aztreonam and the third generation cephalosporins to clinical isolates of E. coli and K pneumoniae. METHODS 107 strains of E.coli and 78 strains of K.pneumoniae were isolated from clinical specimens and detected with disk diffusion method and ESBLs were measured in suspected straims by E test. RESULTS ESBLs detection rate by E test was 15.89% in resiistant strains of E.coli and 24.35% in K. pneumoniae. The resistance rates of E.coli were: 2.8% for aztreonam, 7.5% for ceftriaxone, 8.4% for cefotaxime, 9.3% for ceftazidime and 15.0% for cefoperazone. The resistance rates of K.pneumoniae were: 34.6% for aztreonam, 30.8% for ceftriaxone, 23.1% for cefotaxime, 26.9% for ceftazidime and 23.1% for cefoperazone. CONCLUSION The susceptibility rate of E.coil was higher than that of K.pneumoniae and the strains of K.pneumoniae producing ESBLs were more than that of E.coil strains.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To detect the extended spectrum β lactamases (ESBLs) and the resistance of aztreonam and the third generation cephalosporins to clinical isolates of E. coli and K pneumoniae. METHODS 107 strains of E.coli and 78 strains of K.pneumoniae were isolated from clinical specimens and detected with disk diffusion method and ESBLs were measured in suspected straims by E test. RESULTS ESBLs detection rate by E test was 15.89% in resiistant strains of E.coli and 24.35% in K. pneumoniae. The resistance rates of E.coli were: 2.8% for aztreonam, 7.5% for ceftriaxone, 8.4% for cefotaxime, 9.3% for ceftazidime and 15.0% for cefoperazone. The resistance rates of K.pneumoniae were: 34.6% for aztreonam, 30.8% for ceftriaxone, 23.1% for cefotaxime, 26.9% for ceftazidime and 23.1% for cefoperazone. CONCLUSION The susceptibility rate of E.coil was higher than that of K.pneumoniae and the strains of K.pneumoniae producing ESBLs were more than that of E.coil strains.
Key concepts: Aztreonam, Cefoperazone, Cefotaxime, Ceftazidime, Klebsiella pneumoniae, Microbiology, Ceftriaxone, Cephalosporin